Skip to main content
CVS
NYSE Trade & Services

CVS Beats on Q3, Raises 2026 EPS and Cash Flow Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
8
Price
$91.49
Mkt Cap
$116.911B
52W Low
$69.51
52W High
$110.68
52W Position info
32% above low
Off High info
17% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

CVS sits 32% above its 52-week low of $69.51 on elevated volume (2.4× avg).

Summary

CVS reported Q3 revenue of $108.4 billion (up 5.4%) and Adjusted EPS of $2.09, then raised full-year 2026 Adjusted EPS guidance to at least $8.20 and operating cash flow guidance to at least $15.5 billion.


Key Events · Earnings and Guidance · CVS

  • Q3 Revenue Up 5.4% to $108.4B

    Total revenues rose to $108.4 billion from $102.9 billion, driven by growth in Health Services and Health Care Benefits.

  • Full-Year Guidance Raised Across the Board

    GAAP diluted EPS guidance to at least $6.98 from $6.84-$7.04, Adjusted EPS to at least $8.20 from $7.90-$8.10, and cash flow from operations to at least $15.5 billion from at least $11.5 billion.

  • Aetna Margin Recovery Drives the Beat

    Health Care Benefits adjusted operating income rose to $912 million from $314 million as the medical benefit ratio improved 150 bps to 91.3%.

  • Cash Generation Already at $15.3B YTD

    Year-to-date cash flow from operations of $15.3 billion versus $7.2 billion in the prior-year period.


Analysis · CVS · Trade & Services

The headline is the guidance raise: GAAP diluted EPS to at least $6.98 (from $6.84-$7.04), Adjusted EPS to at least $8.20 (from $7.90-$8.10), and cash flow from operations to at least $15.5 billion from at least $11.5 billion. That cash-flow lift is the standout — roughly $4 billion more than previously guided — and it comes with year-to-date operating cash flow already at $15.3 billion. Aetna is the engine: Health Care Benefits adjusted operating income jumped to $912 million from $314 million as the medical benefit ratio improved 150 basis points to 91.3%, evidence the margin recovery plan is working. Management still flagged elevated cost trends and macro headwinds for the rest of the year, so the raise is not a blank check. This lands one day after reports that CVS is discussing a spin-off of its retail pharmacy division, and a stronger balance sheet and cash generation strengthen its hand in any separation.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CVS was trading at $91.49 on NYSE in the Trade & Services sector, with a market capitalization of approximately $116.9B. The 52-week trading range was $69.51 to $110.68. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $79.60 info
Change: -$0.5287 (-0.66%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $93.20
Real-time Price: $79.60 info
Change: -$13.60 (-15%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.86
Real-time Price: $79.60 info
Change: -$12.26 (-13%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $79.60 info
Change: -$12.24 (-13%) info
Market Cap: $103.433B info
CVS
Nov 03, 2026, 5:35 PM EST
Source: Reuters
Importance Score:
9
Price at Filing: $94.00
Real-time Price: $79.60 info
Change: -$14.40 (-15%) info
Market Cap: $103.433B info